Pharm II Diabetes Exam
1. what Hemoglobin A1c Lebel is diagnostic for diabetes: >6.5%
2. fasting plasma glucose diabetes level: >126
3. 2 hour oral glucose tolerance test diabetic level: >200
4. a random plasma glucose level of what is diagnostic for diabetes: >200 plus
symptoms of hyperglycemia
5. screening for diabetes begins at which age: 35
6. consider screening for children after 10 or puberty if: overweight or obese with >1 risk
factor
7. testing for diabetes in asymptomatic adults of any age if: >1 risk factor
8. women that were diagnosed with GDM need lifelong testing every: 3 years
9. pre diabetic fasting glucose: 100-125
1/7
,10. oral glucose tolerance test prediabetes: 140-199
11. A1c for pre diabetes: 5.7-6.4%
12. what pharmacologic treatment is considered in pts with pre diabetes: metformin
13. when do you test for gestational diabetes in all pregnant women: 24-28 weeks
14. insulin sensitizers include: biguanides
thiazolidinediones
15. insulin secretagogues include: sulfonylureas
meglitinides
16. incretin based therapy includes: GLP-1 agonists
GLP-1/GIP agonist
DPP-4 inhibitors
17. glucose absorption inhibitors include: SGLT2 inhibitors
18. metformin glucose lowering efficacy: high
2/7
, 19. SGLT2 inhibitor glucose lowering efficacy: intermediate to high
20. GLP-1 glucose lowering efficacy: high to very high
21. dual GIP and GLP-1 glucose lowering efficacy: very high
22. DPP-4 inhibitors glucose lowering efficacy: intermediate
23. pioglitazone glucose lowering efficacy: high
24. sulfonylureas glucose lowering efficacy: high
25. insulin glucose lowering efficacy: high to very high
3/7
1. what Hemoglobin A1c Lebel is diagnostic for diabetes: >6.5%
2. fasting plasma glucose diabetes level: >126
3. 2 hour oral glucose tolerance test diabetic level: >200
4. a random plasma glucose level of what is diagnostic for diabetes: >200 plus
symptoms of hyperglycemia
5. screening for diabetes begins at which age: 35
6. consider screening for children after 10 or puberty if: overweight or obese with >1 risk
factor
7. testing for diabetes in asymptomatic adults of any age if: >1 risk factor
8. women that were diagnosed with GDM need lifelong testing every: 3 years
9. pre diabetic fasting glucose: 100-125
1/7
,10. oral glucose tolerance test prediabetes: 140-199
11. A1c for pre diabetes: 5.7-6.4%
12. what pharmacologic treatment is considered in pts with pre diabetes: metformin
13. when do you test for gestational diabetes in all pregnant women: 24-28 weeks
14. insulin sensitizers include: biguanides
thiazolidinediones
15. insulin secretagogues include: sulfonylureas
meglitinides
16. incretin based therapy includes: GLP-1 agonists
GLP-1/GIP agonist
DPP-4 inhibitors
17. glucose absorption inhibitors include: SGLT2 inhibitors
18. metformin glucose lowering efficacy: high
2/7
, 19. SGLT2 inhibitor glucose lowering efficacy: intermediate to high
20. GLP-1 glucose lowering efficacy: high to very high
21. dual GIP and GLP-1 glucose lowering efficacy: very high
22. DPP-4 inhibitors glucose lowering efficacy: intermediate
23. pioglitazone glucose lowering efficacy: high
24. sulfonylureas glucose lowering efficacy: high
25. insulin glucose lowering efficacy: high to very high
3/7
